Yazdi S, Adib Moradi S, Rasoulighasemlouei S, Parouei F, Hashemi M
World J Nucl Med. 2025; 24(1):3-12.
PMID: 39959143
PMC: 11828646.
DOI: 10.1055/s-0044-1788794.
Mun H, Kang B, Kim S, Park G
Tomography. 2025; 11(1.
PMID: 39852690
PMC: 11769435.
DOI: 10.3390/tomography11010010.
Xing X, Cheng S, Huang J
Discov Oncol. 2024; 15(1):497.
PMID: 39331234
PMC: 11436525.
DOI: 10.1007/s12672-024-01343-z.
Fu N, Li J, Wang B, Jiang Y, Li S, Niu R
Gland Surg. 2024; 12(12):1654-1667.
PMID: 38229844
PMC: 10788570.
DOI: 10.21037/gs-23-223.
Chan A, Maya T, Park C, Tak K, Liberman N, Jain R
JACC Cardiovasc Imaging. 2023; 17(2):128-145.
PMID: 37410010
PMC: 11783222.
DOI: 10.1016/j.jcmg.2023.05.007.
PET/MRI of hypoxia and vascular function in ER-positive breast cancer: correlations with immunohistochemistry.
Carmona-Bozo J, Manavaki R, Miller J, Brodie C, Caraco C, Woitek R
Eur Radiol. 2023; 33(9):6168-6178.
PMID: 37166494
PMC: 10415421.
DOI: 10.1007/s00330-023-09572-6.
Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI.
Amano T, Masumoto T, Watanabe D, Hoshiai S, Mori K, Sakamoto N
Jpn J Radiol. 2023; 41(9):938-946.
PMID: 37027094
PMC: 10468932.
DOI: 10.1007/s11604-023-01420-3.
Dynamic Contrast-Enhanced MRI in Abdominal Aortic Aneurysms as a Potential Marker for Disease Progression.
Zhou A, Leach J, Zhu C, Dong H, Jiang F, Lee Y
J Magn Reson Imaging. 2023; 58(4):1258-1267.
PMID: 36747321
PMC: 11737888.
DOI: 10.1002/jmri.28640.
Evaluation of diagnostic efficacy of multimode ultrasound in BI-RADS 4 breast neoplasms and establishment of a predictive model.
Chen Y, Lu J, Li J, Liao J, Huang X, Zhang B
Front Oncol. 2022; 12:1053280.
PMID: 36505867
PMC: 9730703.
DOI: 10.3389/fonc.2022.1053280.
Contrast-Enhanced Cone-Beam Breast CT: An Analysis of Diagnostic Value in Predicting Breast Lesion With Rim Enhancement Malignancy.
Zhao X, Yang J, Zuo Y, Kang W, Liao H, Zheng Z
Front Oncol. 2022; 12:868975.
PMID: 35686106
PMC: 9172967.
DOI: 10.3389/fonc.2022.868975.
The Predictive Value of Magnetic Resonance Imaging-based Texture Analysis in Evaluating Histopathological Grades of Breast Phyllodes Tumor.
Mao Y, Xiong Z, Wu S, Huang Z, Zhang R, He Y
J Breast Cancer. 2022; 25(2):117-130.
PMID: 35506580
PMC: 9065359.
DOI: 10.4048/jbc.2022.25.e14.
Ductal Carcinoma in Situ: State-of-the-Art Review.
Grimm L, Rahbar H, Abdelmalak M, Hall A, Ryser M
Radiology. 2021; 302(2):246-255.
PMID: 34931856
PMC: 8805655.
DOI: 10.1148/radiol.211839.
Diagnosis of Breast Cancer Using Radiomics Models Built Based on Dynamic Contrast Enhanced MRI Combined With Mammography.
Zhao Y, Chen Z, Zhang Y, Zhou J, Chen J, Lee K
Front Oncol. 2021; 11:774248.
PMID: 34869020
PMC: 8637829.
DOI: 10.3389/fonc.2021.774248.
Quantitative Three-Dimensional Assessment of the Pharmacokinetic Parameters of Intra- and Peri-tumoural Tissues on Breast Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Niukkanen A, Okuma H, Sudah M, Auvinen P, Mannermaa A, Liimatainen T
J Digit Imaging. 2021; 34(5):1110-1119.
PMID: 34508299
PMC: 8555007.
DOI: 10.1007/s10278-021-00509-3.
Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis.
Xiao J, Rahbar H, Hippe D, Rendi M, Parker E, Shekar N
NPJ Breast Cancer. 2021; 7(1):42.
PMID: 33863924
PMC: 8052427.
DOI: 10.1038/s41523-021-00247-3.
Abbreviated MR Imaging for Breast Cancer.
Heacock L, Lewin A, Toth H, Moy L, Reig B
Radiol Clin North Am. 2020; 59(1):99-111.
PMID: 33223003
PMC: 8211370.
DOI: 10.1016/j.rcl.2020.09.001.
Combination of DCE-MRI and DWI in Predicting the Treatment Effect of Concurrent Chemoradiotherapy in Esophageal Carcinoma.
Liu C, Sun R, Wang J, Ning F, Wang Z, Luo J
Biomed Res Int. 2020; 2020:2576563.
PMID: 32626736
PMC: 7315287.
DOI: 10.1155/2020/2576563.
Automated volumetric radiomic analysis of breast cancer vascularization improves survival prediction in primary breast cancer.
Dietzel M, Schulz-Wendtland R, Ellmann S, Zoubi R, Wenkel E, Hammon M
Sci Rep. 2020; 10(1):3664.
PMID: 32111898
PMC: 7048934.
DOI: 10.1038/s41598-020-60393-9.
Can enhancement types on preoperative MRI reflect prognostic factors and surgical outcomes in invasive breast cancer?.
Koh J, Park A, Ko K, Jung H
Eur Radiol. 2019; 29(12):7000-7008.
PMID: 31187220
DOI: 10.1007/s00330-019-06236-2.
Kinetic Features of Invasive Breast Cancers on Computer-Aided Diagnosis Using 3T MRI Data: Correlation with Clinical and Pathologic Prognostic Factors.
Song S, Cho K, Seo B, Woo O, Jung S, Sung D
Korean J Radiol. 2019; 20(3):411-421.
PMID: 30799572
PMC: 6389817.
DOI: 10.3348/kjr.2018.0587.